On November 10th, the Bellvitge Biomedical Research Institute (IDIBELL) was awarded the “Company with Value” badge by Vàlua entities. This award rewards the collaboration and commitment of IDIBELL with this platform and with equal opportunities of all people. A “Company with Value” is a company committed to citizenship: a company that cares about the well-being […]
IDIBELL, a ”Company with Value” Read More »
Researchers of the Sarcoma research group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Òscar Martínez-Tirado, have first described the methylation profile of Ewing’s sarcoma (ES), a cancer of bone and soft tissues that mainly affects children and teenagers. Their analysis has unveiled the potential of the PTRF gene as a prognostic marker
The first analysis of Ewing’s sarcoma methyloma opens doors to new treatments Read More »
Yesterday, November 28th, the ‘Best ideas 2016’ award ceremony, yearly organized by Diario Médico, took place in the National Theater of Catalonia (TNC). Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have been awarded a prize in this year’s edition, which aims to be a recognition of the work of professionals, institutions and companies that
The EPICUP test, amongst the “Best ideas” 2016 Read More »
Researchers from the Cognition and Cerebral Plasticity group of the Bellvitge Biomedical Research Institute and the University of Barcelona (IDIBELL-UB), in collaboration with researchers from the University of McGill (Montreal), have published a new study in which brain mechanisms associated to the lack of sensitivity to music are explained. The study, published by PNAS journal,
How does the brain of people who do not like music work? Read More »
The “Viladecans Against Cancer” Association delivers the funds raised during the second edition of its traditional Paella
11.850 euros for the investigation of children’s sarcoma in IDIBELL Read More »
Easing the arrival of advanced therapies from the pre-clinical stages to industrial production and clinical application: this is the goal of the ADVANCECAT project, an accelerator consisting of eighteen health organizations, including universities, companies, private foundations and biomedical research institutes including the Bellvitge Biomedical Research Institute (IDIBELL) through the participation of its research groups in
IDIBELL joins the ADVANCECAT project to promote advanced therapies in Catalonia Read More »
November 7th Carlos III Health Institute Bellvitge Biomedical Research Institute (IDIBELL) tackle together certain topics on the management and monitoring of this type of biomedical research projects Mª Jesús Toledo and Isabel Sastre the participants’ proposals the information and publicity channels of Structural Funds or the procurement of goods and services considerations and good practices most common difficulties disseminate good practices in the management of resources coming from Europe establish mechanisms to identify them.
Good practices in the management of European FEDER/FSE research grants Read More »
Raquel Egea Dr. Jaume Reventós Medesalud 2016 innovation in health “Innovation in hospitals, experiences in Europe” “Models of research and innovation in health” the evolution of Innovation in Catalonia as a model to follow 350 participants exceptional opportunity to establish contacts with industry leaders in the Latin American region
IDIBELL’s innovation strategy in Medesalud 2016 Read More »
A new study by researchers at the Bellvitge Biomedical Research Institute (IDIBELL) has found a cause of multiple resistance in cancer chemotherapy. The work, published today in the Proceedings of the National Academy of Science (PNAS) journal, the organ of expression of the United States Academy of Sciences, has been carried out by the research
Scientists discover a cause of multiple resistance to cancer chemotherapy Read More »
Three research teams from the Bellvitge Biomedical Research Institute (IDIBELL), led by Drs Antonio Agudo, Genevieve Buckland and Sara Kozma Marató de TV3 Foundation diabetes and obesity Controlling weight and reducing obesity through dietary intervention and physical activity in breast cancer survivors Dr. Agudo Chrono-nutrition and chronotype and its relationship with obesity and type II diabetes in the study of a Spanish cohort Dr. Buckland Dr. Kozma Reducing Obesity: Anti-S6K1 Therapy
